We then evaluated the effects of GRP antagonist RC-3940-11 on viability and cell volume of BPH-1 human prostate epithelial cells and WPMY-1 prostate stromal cells in vitro, and in testosterone-induced BPH in Wistar rats in vivo96. The gene discussed is GRP; the disease is benign prostatic hyperplasia.